Clinical Trials
71 trialsA Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery
Sun Yat-sen University
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors
Huashan Hospital
A Study of HB0025 Injection in Patients With Advanced Renal Cancer
Huabo Biopharm Co., Ltd.
HPI Effect in Robotic Urological Surgery on AKI
Ewha Womans University Mokdong Hospital
A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Robot-assisted Urological Surgeries Using the MicroHand S Robot
The Affiliated Hospital of Qingdao University
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
KEYPAD
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Valveless Trocar Versus Standard Trocar in Robot-assisted Complex Partial Nephrectomy
Regina Elena Cancer Institute
MICROBIOME
Imperial College London
Onco-PDL1s/B2M
University Hospital, Clermont-Ferrand
DEDUCER
Helsinki University Central Hospital
Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
SURF
Centre Hospitalier Universitaire de Besancon
PRORECECA
Herlev and Gentofte Hospital
VISP
Innersight Labs Ltd
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients
RenJi Hospital
Percutaneous Cryoablation Versus Partial Nephrectomy for T1b Renal Tumor
I.M. Sechenov First Moscow State Medical University
The Evaluation of Functional Parenchymal Volume and Split Renal Function Before and After Partial Nephrectomy
I.M. Sechenov First Moscow State Medical University
CUDI-RCC
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
INDIGO
Herlev and Gentofte Hospital
Tolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and Melanoma
Shanghai Junshi Bioscience Co., Ltd.
DC-CIK
Sun Yat-sen University
Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma
West China Hospital
EMERALD
University Hospital, Grenoble
Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies
Cedars-Sinai Medical Center
COMBOREIN
University Hospital, Grenoble
Prospective Analysis of Robot-Assisted Surgery
Instituto do Cancer do Estado de São Paulo
QUANARIE
Centre Hospitalier Universitaire de Besancon
Prospective Randomized Study Comparing Laparoscopic Versus Open Partial Nephrectomy
University of Sao Paulo
Dynamic Measurement of Renal Functional Reserve as a Predictor of Long-Term Renal Function
University of Zurich
VAPANCR
University Hospital, Angers
SURTIME
European Organisation for Research and Treatment of Cancer - EORTC
QUASAR
Consorzio Oncotech
Renal Hypothermia During Partial Nephrectomy
Ottawa Hospital Research Institute
Safety and Feasibility of IRE for SRMs
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Zero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma With T1 Stage
RenJi Hospital
CLOCK
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Efficacy and Safety of IRE for RMs
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor
National Cancer Institute (NCI)
Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor
National Cancer Institute (NCI)
Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
National Cancer Institute (NCI)
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
National Cancer Institute (NCI)
UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer
National Cancer Institute (NCI)
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
National Cancer Institute (NCI)
Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer
National Cancer Institute (NCI)
Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
National Cancer Institute (NCI)
SU006668 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2
National Cancer Institute (NCI)